Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

RedHill Biopharma (RDHL) Interest Coverage Ratio (2016 - 2023)

RedHill Biopharma has reported Interest Coverage Ratio over the past 12 years, most recently at 27.91 for Q2 2023.

  • Quarterly Interest Coverage Ratio rose 1184.06% to 27.91 in Q2 2023 from the year-ago period, while the trailing twelve-month figure was 1.2 through Jun 2023, up 80.7% year-over-year, with the annual reading at 5.45 for FY2025, 27.37% down from the prior year.
  • Interest Coverage Ratio was 27.91 for Q2 2023 at RedHill Biopharma, up from 69.07 in the prior quarter.
  • Over five years, Interest Coverage Ratio peaked at 167.3 in Q2 2019 and troughed at 69.07 in Q1 2023.
  • The 5-year median for Interest Coverage Ratio is 4.29 (2020), against an average of 15.0.
  • Year-over-year, Interest Coverage Ratio surged 2905.64% in 2019 and then plummeted 1723.72% in 2023.
  • A 5-year view of Interest Coverage Ratio shows it stood at 62.91 in 2019, then crashed by 93.12% to 4.33 in 2020, then plummeted by 987.5% to 38.41 in 2021, then rose by 20.52% to 30.53 in 2022, then soared by 191.42% to 27.91 in 2023.
  • Per Business Quant, the three most recent readings for RDHL's Interest Coverage Ratio are 27.91 (Q2 2023), 69.07 (Q1 2023), and 30.53 (Q4 2022).